Zhejiang Ruixin Pharmaceutical Co., Ltd.

Aminoglycoside antibiotics have antibacterial effects on most Enterobacteriaceae, influenza bacilli, Brucella, meningococci, gonococci, Staphylococci (methicillin-sensitive strains) and Mycobacterium tuberculosis, and inhibit protein synthesis by binding to the bacterial ribosome 30S subunit.

It is composed of multiple nucleotide molecules, can induce interferon in the body, has a good effect on diseases caused by various viruses, and can enhance antibody formation and stimulate macrophage phagocytosis.

It is composed of multiple nucleotide molecules, can induce interferon in the body, has a good effect on diseases caused by various viruses, and can enhance antibody formation and stimulate macrophage phagocytosis.

It is composed of multiple nucleotide molecules, can induce interferon in the body, has a good effect on diseases caused by various viruses, and can enhance antibody formation and stimulate macrophage phagocytosis.

It is composed of multiple nucleotide molecules, can induce interferon in the body, has a good effect on diseases caused by various viruses, and can enhance antibody formation and stimulate macrophage phagocytosis.

It is composed of multiple nucleotide molecules, can induce interferon in the body, has a good effect on diseases caused by various viruses, and can enhance antibody formation and stimulate macrophage phagocytosis.

It has a direct relaxant effect on the smooth muscles of the respiratory tract, and partially achieves bronchial dilation by releasing endogenous adrenaline and norepinephrine. As a purine receptor blocker, it can counteract the contractile effect of adenine and other substances on the respiratory tract, and enhance the contractility of the diaphragm to improve respiratory function.

Enhance the water solubility of aminophylline and indirectly support its pharmacological effects.

1. It has a positive inotropic effect on the myocardium, mainly acting on β1 receptors, and has relatively little effect on β2 and α receptors. 2. It can directly excite cardiac β1 receptors to enhance myocardial contraction and increase stroke volume, thereby increasing cardiac output. 3. It can reduce peripheral vascular resistance (reduced afterload), but systolic blood pressure and pulse pressure generally remain unchanged, or only increase due to increased cardiac output. 4. It can reduce ventricular filling pressure and promote atrioventricular node conduction. 5. Myocardial contractility is enhanced, and coronary blood flow and myocardial oxygen consumption often increase. 6. Due to increased cardiac output, renal blood flow and urine volume often increase.

It has a significant effect on increasing the number of peripheral blood leukocytes in normal rabbits. The peak of the leukocyte count occurs on the 4th day after the first administration, which is 72% higher than before the administration, which is better than the leukocyte-raising drug shark liver alcohol. It has a significant effect on increasing leukocytes in rabbits induced by cobalt 60-gamma rays and deep X-ray irradiation. It also has a preventive effect on leukopenia when administered two days before irradiation. It can also prevent leukopenia in mice caused by mitomycin C. It has a synergistic inhibitory effect on solid Ehrlich carcinoma when used in combination with cyclophosphamide, and the toxicity of leukopenia caused by cyclophosphamide is significantly reduced.